Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135622) titled 'Xpert MTB/RIF Ultra Trial' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Nestani Tukvadze
Condition:
Tuberculosis (TB)
Pulmonary TB
Intervention:
Diagnostic Test: Xpert(R) MTB/RIF Ultra
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 27, 2019
Target Sample Size: 778
Countries of Recruitment:
Georgia
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07135622
Published by HT Digital Content Services with permission from Hea...